Terry Adams, MD
Surgery · Sweetwater, TNNPI 1730105610
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Intuitive Surgical at 42.5% of the total. Reporting peaked in 2023 at $14,412 and has fallen 87.2% since, to $1,850 in 2025. Among surgery clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $88.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- Abbott$3K
- Medtronic$3K
- Penumbra, Inc.$2K
- Davol Inc.$2K
- Cardiovascular Systems Inc.$1K
- plus $4K from 31 others
What the payments were for
- Travel & lodging$8,01131%
- Food & beverage$8,91635%
- Education$8,75934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 37 | $10,916 |
| Abbott | 27 | $2,896 |
| Medtronic(2 entities) | 32 | $2,864 |
| Penumbra, Inc. | 15 | $2,277 |
| Davol Inc. | 14 | $2,003 |
| Cardiovascular Systems Inc. | 18 | $1,085 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 41 | $823 |
| Silk Road Medical, Inc. | 16 | $559 |
| Endologix LLC | 14 | $352 |
| AbbVie(2 entities) | 6 | $202 |
| Johnson & Johnson(3 entities) | 12 | $202 |
| Inari Medical, Inc. | 4 | $184 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $177 |
| Conmed Corporation | 5 | $169 |
| Organogenesis Inc. | 10 | $151 |
| Merck | 5 | $128 |
| Shockwave Medical, Inc | 2 | $76 |
| Bard Peripheral Vascular, Inc. | 1 | $72 |
| Neurocrine Biosciences, Inc. | 3 | $66 |
| Lemaitre Vascular, Inc. | 2 | $59 |
| Pfizer | 3 | $52 |
| Nevro Corp. | 1 | $48 |
| Amgen | 2 | $40 |
| Novo Nordisk | 1 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Philips North America LLC | 2 | $26 |
| Radius Health, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Solventum Corporation | 1 | $16 |
| Neotract Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Cordis US CORP. | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Endogastric Solutions, Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,750
- OMNILINK ELITE$1,904
- Indigo System$1,836
- TurboHawk$1,621
- Da Vinci Surgical System$1,150
- Peripheral Orbital Atherectomy System$795
- PHASIX$287
- ENROUTE Transcarotid Neuroprotection System$167
- ENROUTE Transcarotid Stent$167
- HawkOne$139
- Phasix Mesh$127
- DALVANCE$119
How this compares
$25,686 in reported general payments places this provider in the 90th percentile of 516 surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $26,411 |
| XareltoRivaroxaban | 45 | $25,257 |
| ClopidogrelClopidogrel Bisulfate | 81 | $451 |
| Ketorolac Tromethamine | 11 | $170 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $134 |
| Cephalexin | 16 | $127 |
| Clindamycin Hcl | 11 | $103 |
| Rosuvastatin Calcium | 17 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $52 | $26,41146 claims |
| Johnson & JohnsonXarelto | $202 | $25,25745 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 516 surgery providers in Tennessee.
Other surgery in Sweetwater
- Heath BroussardJackson$688K
- Eric WallaceCookeville$529K
- John RobertsonJohnson City$432K
- Jaime Ponce-PortugalChattanooga$412K
- Evelio RodriguezNashville$362K
- Mathew NinanNashville$298K
- Joseph BroucekNashville$262K
- Linda HanGermantown$252K
- Myron StokesCordova$240K
- Kenneth CutshallJohnson City$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.